(Q36165742)

12 August 2017

1 reference

title

Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? (English)

1 reference

12 August 2017

0 references

1 reference

Chlamydophila pneumoniae

object named as

Chlamydophila pneumoniae

1 reference

based on heuristic

inferred from title

Mycoplasma pneumoniae

object named as

Mycoplasma pneumoniae

1 reference

Sebastian L Johnston

1

1 reference

12 August 2017

Richard J Martin

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

16 June 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

12 August 2017

published in

1 reference

12 August 2017

volume

172

1 reference

12 August 2017

issue

9

1 reference

12 August 2017

page(s)

1078-1089

1 reference

Community study of role of viral infections in exacerbations of asthma in 9-11 year old children

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Histamine decreases E-cadherin-based adhesion to increase permeability of human airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia pneumoniae, strain TWAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Mycoplasma pneumoniae infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Mycoplasma pneumoniae and its role as a human pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Laboratory diagnosis of Mycoplasma pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia pneumoniae infections in asthma: clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Comparison of a new quantitative ompA-based real-Time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Serology of chlamydia in relation to asthma and bronchial hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia pneumoniae and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Serologic markers for Chlamydia pneumoniae in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia pneumoniae serological status is not associated with asthma in children or young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Host immune response to Chlamydia pneumoniae heat shock protein 60 is associated with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: respiratory morbidity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Seroprevalence of chronic Chlamydia pneumoniae infection in patients affected by chronic stable asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia pneumoniae and severity of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

The development of asthma in children infected with Chlamydia pneumoniae is dependent on the modifying effect of mannose-binding lectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Increased frequency of detection of Chlamydophila pneumoniae in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia pneumoniae infection and inflammation in adults with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

A link between chronic asthma and chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Use of quantitative and objective enzyme immunoassays to investigate the possible association between Chlamydia pneumoniae and Mycoplasma pneumoniae antibodies and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Asthma, atopy and Chlamydia pneumoniae antibodies in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Lack of correlation between Chlamydia pneumoniae antibody titers and adult-onset asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia pneumoniae and newly diagnosed asthma: a case-control study in 1 to 6-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

The association of Chlamydia pneumoniae infection and reactive airway disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chronic Chlamydia pneumoniae infection and asthma exacerbations in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia pneumoniae and exacerbations of asthma in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Anti-Chlamydia pneumoniae heat shock protein 10 antibodies in asthmatic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Atypical pathogen infection in adults with acute exacerbation of bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Role of viruses and atypical bacteria in exacerbations of asthma in hospitalized children: a prospective study in the Nord-Pas de Calais region (France).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Respiratory symptoms, asthma, atopy and Chlamydia pneumoniae IgG antibodies in a general population sample of young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Macrolide and occult infection in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Infection and activation of airway epithelial cells by Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Transcription factors and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Interferon-beta induction by Chlamydia pneumoniae in human smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Matrix metalloproteinases in the pathogenesis of asthma and COPD: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia and apoptosis: life and death decisions of an intracellular pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Mycoplasma pulmonis infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Activity of gemifloxacin and other new quinolones against Chlamydia pneumoniae: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Review of macrolides and ketolides: focus on respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Is there a role for antibiotics in the treatment of asthma?: involvement of atypical organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Macrolides for the treatment of chronic sinusitis, asthma, and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Recall helper T cell response: T helper 1 cell-resistant allergic susceptibility without biasing uncommitted CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Effects of salicylate and related compounds on fusidic acid MICs in Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Lung concentrations of telithromycin after oral dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

21 January 2018

Antibiotics in asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Immunomodulatory activity and effectiveness of macrolides in chronic airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Anti-inflammatory effects of macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Inhibition of secretion of interleukin-1alpha and tumor necrosis factor alpha by the ketolide antibiotic telithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Anaerobic bacteria commonly colonize the lower airways of intubated ICU patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Diffuse panbronchiolitis: role of macrolides in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

A defective type 1 response to rhinovirus in atopic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200412-1743PP

10.1164/RCCM.200412-1743PP

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference